생체흡수성 임플란트 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)
Global Bioresorbable Implants Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1521394
리서치사:Value Market Research
발행일:2024년 07월
페이지 정보:영문 173 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
생체흡수성 임플란트 시장의 세계 수요는 2023년 75억 8,000만 달러에서 2032년에는 159억 7,000만 달러 가까운 시장 규모에 달할 것으로 추정되며, 조사 기간인 2024-2032년 CAGR은 8.63%입니다.
생체흡수성 임플란트는 서서히 분해되어 체내에 흡수되도록 설계된 의료기기입니다. 일반적으로 정형외과, 심혈관 시술, 조직 공학 등 다양한 의료 용도에서 일시적인 지원 및 치료에 사용됩니다. 이러한 임플란트는 종종 고분자 또는 금속과 같은 생체 적합성 재료로 만들어지며, 체내에서 안전하게 대사되거나 배설되는 무독성 부산물로 분해됩니다. 이러한 특징은 외과적 제거의 필요성을 없애고 장기적인 합병증 위험을 낮추며 조직 치유와 재생을 촉진합니다.
시장 역학
생체흡수성 임플란트 시장은 생명공학 및 재료과학의 발전으로 인해 체내에서 시간이 지남에 따라 분해되는 의료기기를 개발하고자 하는 바이오테크놀러지와 재료과학의 발전에 힘입어 성장하고 있습니다. 제어된 분해 속도와 최적의 기계적 특성을 가능하게 하는 기술 혁신은 정형외과, 심혈관 및 연부조직 수술에서 이러한 임플란트의 안전성과 효능을 향상시키고 있습니다. 의료기기 제조에서 생체흡수성 재료를 지원하는 규제 승인은 제품의 안전성과 생체적합성을 보장함으로써 시장 성장을 가속합니다. 최소침습 수술 기술과 맞춤형 의료에 대한 수요가 증가하면서 자연 치유를 촉진하고 장기적인 의료 비용을 절감하는 생체흡수성 임플란트의 채택을 촉진하고 있습니다.
학계 연구자, 의료 서비스 프로바이더 및 생명공학 기업 간의 공동 연구는 생체흡수성 재료 및 임플란트 설계의 혁신을 촉진하고 임상 과제를 해결하고 시장 기회를 확대할 수 있도록 돕습니다. 이물 반응을 최소화하고 조직 통합을 촉진하는 임플란트에 대한 환자 선호도는 시장 확대를 더욱 가속화하고 있습니다. 또한 의료 인프라에 대한 투자와 세계 의료비 증가는 첨단 수술 기술과 생체 재료의 채택을 촉진하여 시장 성장을 가속하고 있습니다. 그러나 생체흡수성 임플란트의 높은 비용과 엄격한 규제 승인 절차는 향후 수년간 시장 성장에 걸림돌이 될 수 있습니다.
조사 리포트는 Porter's Five Forces 모델, 시장의 매력 분석, 밸류체인 분석을 커버하고 있습니다. 이러한 툴은 업계의 구조를 명확하게 파악하고, 세계 레벨에서의 경쟁 매력을 평가하는데 도움이 됩니다. 또한 이러한 툴은 세계의 생체흡수성 임플란트 시장의 각 부문을 종합적으로 평가할 수도 있습니다. 생체흡수성 임플란트 산업의 성장과 동향은 이 조사에 전체적인 어프로치를 제공합니다.
시장 세분화
생체흡수성 임플란트 시장 보고서의 이 섹션에서는 국가 및 지역 레벨 부문에 관한 상세 데이터를 제공하며, 이에 따라 전략가가 향후 기회에 각각의 제품 및 서비스의 타깃층을 식별하는데 도움이 됩니다.
이 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 & 아프리카 생체흡수성 임플란트 시장의 현재 및 향후 수요를 강조하는 지역 전망을 다루고 있습니다. 또한 이 리포트에서는 모든 주요 지역에서 개별 애플리케이션 부문의 수요, 추정·예측에 초점을 맞추고 있습니다.
커스텀 요건이 있는 경우, 문의해주시기 바랍니다. 당사의 조사 팀이 고객의 요구에 따라 맞춤형 보고서를 제공할 수 있습니다.
The global demand for Bioresorbable Implants Market is presumed to reach the market size of nearly USD 15.97 Billion by 2032 from USD 7.58 Billion in 2023 with a CAGR of 8.63% under the study period 2024-2032.
Bioresorbable implants are medical devices designed to degrade and be absorbed by the body gradually. They are typically used to provide temporary support or treatment in various medical applications, such as orthopedics, cardiovascular procedures, and tissue engineering. These implants are often made from biocompatible materials, such as polymers or metals, that break down into non-toxic byproducts that can be safely metabolized or excreted by the body. This feature eliminates the need for surgical removal, lowers the risk of long-term complications, and promotes tissue healing and regeneration.
MARKET DYNAMICS
The market for bioresorbable implants is driven by advancements in biotechnology and materials science aimed at developing medical devices that degrade over time within the body. Technological innovations enabling controlled degradation rates and optimal mechanical properties enhance the safety and efficacy of these implants in orthopedic, cardiovascular, and soft tissue surgeries. Regulatory approvals supporting bioresorbable materials in medical device manufacturing foster market growth by ensuring product safety and biocompatibility. Rising demand for minimally invasive surgical techniques and personalized medicine drives the adoption of bioresorbable implants that promote natural tissue healing and reduce long-term healthcare costs.
Collaborations between academic researchers, healthcare providers, and biotechnology firms drive innovation in bioresorbable materials and implant design, addressing clinical challenges and expanding market opportunities. Patient preference for implants that minimize foreign body reactions and facilitate tissue integration further accelerates market expansion. Moreover, investments in healthcare infrastructure and rising healthcare expenditures globally support adopting advanced surgical technologies and biomaterials, propelling market growth. However, the high cost of bioresorbable implants and stringent regulatory approval processes may challenge market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioresorbable Implants. The growth and trends of Bioresorbable Implants industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Bioresorbable Implants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Bioresorbable Implants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioresorbable Implants market include Bioretec, Conmed Corporation, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, Boston Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-User
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL BIORESORBABLE IMPLANTS MARKET ANALYSIS BY TYPE
5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Metallic Historic and Forecast Sales By Regions
5.4. Polymer (PLGA-Poly Lactic-co-glycolic Acid, PLLA-Poly L-lactide, PGA-Polyglycolic Acid, PLA-Polylactic Acid, Others) Historic and Forecast Sales By Regions
6. GLOBAL BIORESORBABLE IMPLANTS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Orthopedic Historic and Forecast Sales By Regions
6.4. Cardiovascular Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions
7. GLOBAL BIORESORBABLE IMPLANTS MARKET ANALYSIS BY END-USER
7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Hospital Historic and Forecast Sales By Regions
7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions
8. GLOBAL BIORESORBABLE IMPLANTS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE BIORESORBABLE IMPLANTS COMPANIES
9.1. Bioresorbable Implants Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF BIORESORBABLE IMPLANTS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Bioretec
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Conmed Corporation
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. DePuy Synthes
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Stryker Corporation
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Zimmer Biomet Holdings
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Smith & Nephew
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Boston Scientific Corporation
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
